Premium
Lack of benefits of mammalian target of rapamycin inhibitor in patients transplanted for hepatocellular carcinoma: Is this the end of the story?
Author(s) -
Geissler Edward K.,
Schnitzbauer Andreas A.,
Schlitt Hans J.
Publication year - 2016
Publication title -
liver transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.814
H-Index - 150
eISSN - 1527-6473
pISSN - 1527-6465
DOI - 10.1002/lt.24464
Subject(s) - medicine , sirolimus , liver transplantation , hepatocellular carcinoma , milan criteria , transplantation , oncology , population , surgery , environmental health